CommercialCoverageMedium impact
Lysis of Epidural Adhesions 7.01.73
Excellus BlueCross BlueShield·Orthopedics, Pain Management, Neurosurgery·Bone & Joints (Orthopedic)
Effective date
Oct 15, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield policy 7.01.73 effective October 15, 2025 considers lysis of epidural adhesions (catheter-based or endoscopic) for back pain treatment as investigational and not covered. This affects billing for epidural adhesiolysis procedures in orthopedic and pain management practices.
Action Required
By October 15, 2025: Billing team must update system to flag lysis of epidural adhesions procedures as non-covered for Excellus BlueCross BlueShield plans. Notify providers that catheter-based and endoscopic epidural adhesiolysis will be denied as investigational. Update prior authorization systems to reflect non-coverage status.